Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VSee Health ( (VSEE) ) just unveiled an announcement.
VSee Health, Inc. received a notice from Nasdaq on August 20, 2025, for non-compliance with listing rules due to delayed filing of required reports with the SEC. The company is scheduled for a hearing on September 9, 2025, to appeal the decision to delist its stock and warrants from Nasdaq, with trading expected to move to OTC Markets if delisting proceeds. The potential delisting could limit market accessibility for shareholders and affect stock prices.
The most recent analyst rating on (VSEE) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral.
VSee Health’s strong revenue growth and recent strategic contracts position it well in a growing industry. However, the company’s financial instability, marked by negative profitability and cash flow, presents significant risks. Positive technical indicators and strategic corporate events support the stock, but the negative valuation metrics remain a concern.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
VSee Health is a rapidly growing leader in AI-powered telehealth, operating in the $787 billion digital healthcare market. The company offers a modular, no-code/low-code platform trusted by over 1,000 clients, including NASA and the U.S. Department of Health and Human Services, providing solutions such as critical care, teleradiology, and autonomous robotics to enhance healthcare operations and efficiency.
Average Trading Volume: 758,566
Technical Sentiment Signal: Sell
Current Market Cap: $12.08M
See more data about VSEE stock on TipRanks’ Stock Analysis page.